Table 3.
Univariate and multivariate analyses of PFS for Stage I-IV and stage I-II OCCC.
| Univariate analysis |
Mulivariate analysis |
|||||
|---|---|---|---|---|---|---|
| Factors | HR | 95% CI | P values | HR | 95% CI | P values |
| Stage I-IV | ||||||
| Age (> 55 vs ≤ 55) | 3.4 | 1.3–10.4 | 0.0109 | 2.2 | 0.8–7.0 | 0.1137 |
| FIGO stage (I,II vs III, IV) | 5.6 | 2.3–13.8 | 0.0003 | 3.9 | 1.5–9.8 | 0.0049 |
| Ascites cytology (negative vs positive) | 3.4 | 1.4–8.5 | 0.0069 | 2.5 | 1.0–6.5 | 0.0467 |
| Residual tumor (no vs yes ) | 7.5 | 2.9–18.8 | 0.0001 | |||
| NeoAg freq (low vs high) | 3.4 | 1.3–10.5 | 0.0103 | 2.9 | 1.1–8.9 | 0.0326 |
| Stage I-II | ||||||
| Age (> 55 vs ≤ 55) | 2.2 | 0.6–8.6 | 0.2189 | |||
| Ascites cytology (negative vs positive) | 2.2 | 0.6–7.8 | 0.2407 | 2 | 0.5–7.2 | 0.2906 |
| NeoAg freq (low vs high) | 10.1 | 1.9–186.7 | 0.004 | 9.9 | 1.9–182.9 | 0.0045 |